ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $231,000 | +29.8% | 19,637 | +13.2% | 0.02% | +90.9% |
| Q4 2018 | $178,000 | -32.8% | 17,345 | +36.3% | 0.01% | -67.6% |
| Q1 2017 | $265,000 | -21.4% | 12,726 | +24.9% | 0.03% | +13.3% |
| Q4 2015 | $337,000 | -80.7% | 10,191 | -80.8% | 0.03% | -80.0% |
| Q3 2015 | $1,742,000 | +229.3% | 53,181 | +431.8% | 0.15% | +154.2% |
| Q2 2015 | $529,000 | -35.2% | 10,000 | -64.7% | 0.06% | -28.9% |
| Q1 2015 | $816,000 | – | 28,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |